Literature DB >> 28701406

Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.

Julianna S Deakyne1, Kimberly A Malecka1, Troy E Messick2, Paul M Lieberman2.   

Abstract

Epstein-Barr virus (EBV) establishes a stable latent infection that can persist for the life of the host. EBNA1 is required for the replication, maintenance, and segregation of the latent episome, but the structural features of EBNA1 that confer each of these functions are not completely understood. Here, we have solved the X-ray crystal structure of an EBNA1 DNA-binding domain (DBD) and discovered a novel hexameric ring oligomeric form. The oligomeric interface pivoted around residue T585 as a joint that links and stabilizes higher-order EBNA1 complexes. Substitution mutations around the interface destabilized higher-order complex formation and altered the cooperative DNA-binding properties of EBNA1. Mutations had both positive and negative effects on EBNA1-dependent DNA replication and episome maintenance with OriP. We found that one naturally occurring polymorphism in the oligomer interface (T585P) had greater cooperative DNA binding in vitro, minor defects in DNA replication, and pronounced defects in episome maintenance. The T585P mutant was compromised for binding to OriP in vivo as well as for assembling the origin recognition complex subunit 2 (ORC2) and trimethylated histone 3 lysine 4 (H3K4me3) at OriP. The T585P mutant was also compromised for forming stable subnuclear foci in living cells. These findings reveal a novel oligomeric structure of EBNA1 with an interface subject to naturally occurring polymorphisms that modulate EBNA1 functional properties. We propose that EBNA1 dimers can assemble into higher-order oligomeric structures important for diverse functions of EBNA1.IMPORTANCE Epstein-Barr virus is a human gammaherpesvirus that is causally associated with various cancers. Carcinogenic properties are linked to the ability of the virus to persist in the latent form for the lifetime of the host. EBNA1 is a sequence-specific DNA-binding protein that is consistently expressed in EBV tumors and is the only viral protein required to maintain the viral episome during latency. The structural and biochemical mechanisms by which EBNA1 allows the long-term persistence of the EBV genome are currently unclear. Here, we have solved the crystal structure of an EBNA1 hexameric ring and characterized key residues in the interface required for higher-order complex formation and long-term plasmid maintenance.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  DNA-binding domain; EBNA1; Epstein-Barr virus; OriP; cooperative binding; episome maintenance; hexameric ring; oligomers; viral latency

Mesh:

Substances:

Year:  2017        PMID: 28701406      PMCID: PMC5599765          DOI: 10.1128/JVI.01046-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1.

Authors:  W Su; T Middleton; B Sugden; H Echols
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication.

Authors:  Zhong Deng; Larissa Lezina; Chi-Ju Chen; Svetlana Shtivelband; Wingkan So; Paul M Lieberman
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

3.  Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA.

Authors:  J M Bashaw; J L Yates
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Virology. Epstein-Barr virus turns 50.

Authors:  Paul M Lieberman
Journal:  Science       Date:  2014-03-21       Impact factor: 47.728

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Epstein-Barr virus nuclear antigen type 1 binding: electron microscopy.

Authors:  I Hirsch; J Reischig; O Benada; D Bartsch; B Brichácek; L Boguszaková; V Vonka
Journal:  J Virol Methods       Date:  1988-12       Impact factor: 2.014

7.  Modelling the structure of full-length Epstein-Barr virus nuclear antigen 1.

Authors:  Mushtaq Hussain; Derek Gatherer; Joanna B Wilson
Journal:  Virus Genes       Date:  2014-07-11       Impact factor: 2.332

8.  The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells.

Authors:  Asuka Nanbo; Arthur Sugden; Bill Sugden
Journal:  EMBO J       Date:  2007-09-13       Impact factor: 11.598

9.  Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.

Authors:  Gabriel Santpere; Fleur Darre; Soledad Blanco; Antonio Alcami; Pablo Villoslada; M Mar Albà; Arcadi Navarro
Journal:  Genome Biol Evol       Date:  2014-04       Impact factor: 3.416

10.  A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.

Authors:  Jan Hellert; Magdalena Weidner-Glunde; Joern Krausze; Ulrike Richter; Heiko Adler; Roman Fedorov; Marcel Pietrek; Jessica Rückert; Christiane Ritter; Thomas F Schulz; Thorsten Lührs
Journal:  PLoS Pathog       Date:  2013-10-17       Impact factor: 6.823

View more
  13 in total

Review 1.  Hitchhiking of Viral Genomes on Cellular Chromosomes.

Authors:  Tami L Coursey; Alison A McBride
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

2.  Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.

Authors:  Kimberly A Malecka; Jayaraju Dheekollu; Julianna S Deakyne; Andreas Wiedmer; Ursula D Ramirez; Paul M Lieberman; Troy E Messick
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

3.  Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus oriP.

Authors:  Yang Mei; Troy E Messick; Jayaraju Dheekollu; Hee Jong Kim; Sudheer Molugu; Leonardo Josué Castro Muñoz; Vera Moiskeenkova-Bell; Kenji Murakami; Paul M Lieberman
Journal:  J Virol       Date:  2022-08-29       Impact factor: 6.549

4.  Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL).

Authors:  Racha Bahri; François Boyer; Mohamad Adnan Halabi; Alain Chaunavel; Jean Feuillard; Arnaud Jaccard; Sylvie Ranger-Rogez
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

5.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

Review 6.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

7.  Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance.

Authors:  Jayaraju Dheekollu; Andreas Wiedmer; Kasirajan Ayyanathan; Julianna S Deakyne; Troy E Messick; Paul M Lieberman
Journal:  Cell       Date:  2021-01-21       Impact factor: 41.582

Review 8.  Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.

Authors:  Pok Man Hau; Hong Lok Lung; Man Wu; Chi Man Tsang; Ka-Leung Wong; Nai Ki Mak; Kwok Wai Lo
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

9.  Curcumin Inhibits Proliferation of Epstein-Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression.

Authors:  Limei Liu; Jiaomin Yang; Wuguang Ji; Chao Wang
Journal:  Biomed Res Int       Date:  2019-10-07       Impact factor: 3.411

Review 10.  EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.

Authors:  Joanna B Wilson; Evelyne Manet; Henri Gruffat; Pierre Busson; Marc Blondel; Robin Fahraeus
Journal:  Cancers (Basel)       Date:  2018-04-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.